Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43738, first published .
Implementing Blended Care to Discontinue Benzodiazepine Receptor Agonist Use for Insomnia: Process Evaluation of a Pragmatic Cluster Randomized Controlled Trial

Implementing Blended Care to Discontinue Benzodiazepine Receptor Agonist Use for Insomnia: Process Evaluation of a Pragmatic Cluster Randomized Controlled Trial

Implementing Blended Care to Discontinue Benzodiazepine Receptor Agonist Use for Insomnia: Process Evaluation of a Pragmatic Cluster Randomized Controlled Trial

Journals

  1. Coteur K, Van Nuland M, Schoenmakers B, Van den Broeck K, Anthierens S. “At the time I only wanted to relieve stress”: Exploring motivation for behaviour change in long-term hypnotic users. Heliyon 2023;9(5):e16215 View
  2. Coteur K, Peters S, Jansen P, Schoenmakers B, Van Nuland M. Reducing long‐term use of benzodiazepine receptor agonists: In‐depth interview study with primary care stakeholders. Health Expectations 2024;27(1) View
  3. Soyka M, Wild I, Caulet B, Leontiou C, Lugoboni F, Hajak G. Long-term use of benzodiazepines in chronic insomnia: a European perspective. Frontiers in Psychiatry 2023;14 View
  4. Lee Y, Kim I, Lee S, Yu S. Information and Communication Technology-Based Application for Cognitive Behavioral Therapy among Community-Dwelling Older Adults with Insomnia: Development and Validation Study. Healthcare 2024;12(1):106 View
  5. Swierzbiolek B, Oldenhof E, Byrne J, Staiger P. ‘Let’s talk about sleep health’ within primary care: a qualitative study of patients’ willingness to engage in psychological interventions for insomnia. British Journal of General Practice 2024:BJGP.2023.0310 View